| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/04/2013 | CN103271852A Massage oil containing prinsepia utilis royle oil and preparation method of massage oil |
| 09/04/2013 | CN102813797B Preparation method of traditional Chinese medicine for treating intemperance type insomnia |
| 09/04/2013 | CN102793904B Preparation method for traditional Chinese medicine lotion for treatment of confusing-type closed fracture |
| 09/04/2013 | CN102784372B Preparation method of traditional Chinese medicine for treating spleen deficiency insomnia |
| 09/04/2013 | CN102784357B Method for preparing traditional Chinese medicine for treating insomnia caused by addiction to strong tea |
| 09/04/2013 | CN102727834B Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof |
| 09/04/2013 | CN102579844B Medicine for treating Meniere's disease |
| 09/04/2013 | CN102533918B Method for preparing rapeseed active polypeptides |
| 09/04/2013 | CN102526496B Traditional Chinese medicine composition for treating fire excess from yin deficiency type sleepless night sweating symptoms, and preparation method of traditional Chinese medicine composition |
| 09/04/2013 | CN102526214B Traditional Chinese medicine preparation for treating angioneurotic headache and migraine |
| 09/04/2013 | CN102526047B Preparing method of model of monkey with chronic systemic Parkinson's disease |
| 09/04/2013 | CN102379949B Preparation process of sini powder |
| 09/04/2013 | CN102358735B Low toxicity multiple-point guided drug, nitrogen-containing aromatic ring CB1 receptor inhibitor with hydroxyl or substituted hydroxyl, and pharmaceutical use thereof |
| 09/04/2013 | CN102079699B New crystal form for sodium valproate and preparation method and usage thereof |
| 09/04/2013 | CN102046627B GABAA receptor modulators |
| 09/04/2013 | CN101842388B Humanized antibodies against the beta-amyloyd peptide |
| 09/04/2013 | CN101837003B Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/04/2013 | CN101633689B Peptide selection method |
| 09/04/2013 | CN101415729B Antibodies against amyloid-beta peptide |
| 09/03/2013 | US8524780 Deuterium-enriched bupropion |
| 09/03/2013 | US8524746 Dosage regimen for COMT inhibitors |
| 09/03/2013 | US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/03/2013 | US8524703 Bridgehead amine ring-fused indoles and indolines |
| 09/03/2013 | US8524700 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 09/03/2013 | US8524694 Aminoalkylsterol compounds with antitumoral and neuroprotective activity |
| 09/03/2013 | US8524672 Method for inhibiting BAFF-R activity |
| 09/03/2013 | US8524665 Use of secretin in treatments of disorders associated with the amygdala |
| 09/03/2013 | US8524446 Method for detecting adeno-associated virus |
| 09/03/2013 | US8524279 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale. |
| 09/03/2013 | CA2747000C Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 09/03/2013 | CA2667372C 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulators |
| 09/03/2013 | CA2567704C Selective serotonin receptor inverse agonists as therapeutics for disease |
| 09/03/2013 | CA2565029C Immediate release pharmaceutical tablets with height greater than width |
| 09/03/2013 | CA2561696C Novel modified galectin 9 proteins and use thereof |
| 09/03/2013 | CA2421865C Olfactory and pheromones g-protein coupled receptors |
| 09/03/2013 | CA2398277C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity |
| 08/29/2013 | WO2013126205A1 Mixed monoamine reuptake inhibitor in a biodegradable polymer carrier |
| 08/29/2013 | WO2013125225A1 Composition for preventing or treating allergic disease or major depressive disorder (depression) |
| 08/29/2013 | WO2013124416A1 Calcineurin inhibitors for use in the treatment of lesional vestibular disorders |
| 08/29/2013 | WO2013124413A1 Thiadiazolidinediones as gsk-3 inhibitors |
| 08/29/2013 | WO2013124341A1 Substituted pyrazolo[1,5-a]pyridines, their preparation and use as medicaments |
| 08/29/2013 | WO2013124169A1 Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| 08/29/2013 | WO2013124158A1 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| 08/29/2013 | WO2013124026A1 8 - substituted 2 -amino - [1,2,4] triazolo [1, 5 -a] pyrazines as syk tryrosine kinase inhibitors and gcn2 serin kinase inhibitors |
| 08/29/2013 | WO2010109318A8 Process for the preparation of herbal extract of cassia tora leaves for treating anxiety disorders |
| 08/29/2013 | US20130225648 Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives |
| 08/29/2013 | US20130225531 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 08/29/2013 | US20130225499 Method for administering omega-conopeptide |
| 08/29/2013 | US20130224301 Solid pharmaceutical dispersions with enhanced bioavailability |
| 08/29/2013 | US20130224289 Gastric retained gabapentin dosage form |
| 08/29/2013 | US20130224169 Composition and method for recovery from mild traumatic brain injury |
| 08/28/2013 | EP2631242A2 A process for concentration of a polypeptide |
| 08/28/2013 | EP2631236A1 Substituted pyrazolo[1,5-a]pyridines, their preparation and use as medicaments |
| 08/28/2013 | EP2631229A1 P2x4 receptor antagonist |
| 08/28/2013 | EP2630965A1 A polypeptide for the protection from neurodegeneration in patients with amyotrophic lateral sclerosis (ALS) |
| 08/28/2013 | EP2630962A1 Low Frequency Glatiramer Acetate Therapy |
| 08/28/2013 | EP2630954A1 Pulmonary delivery for levodopa |
| 08/28/2013 | EP2630150A2 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain |
| 08/28/2013 | EP2630139A1 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors |
| 08/28/2013 | EP2630136A1 Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases |
| 08/28/2013 | EP2630123A1 Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| 08/28/2013 | EP2630122A1 Arylamide derivatives as ttx-s blockers |
| 08/28/2013 | EP2629776A2 Compounds, compositions and methods useful for cholesterol mobilisation |
| 08/28/2013 | EP2629774A2 Chemosensory receptor ligand-based therapies |
| 08/28/2013 | EP2629773A2 Chemosensory receptor ligand-based therapies |
| 08/28/2013 | EP2629766A2 Combination therapy |
| 08/28/2013 | CN203153237U Drug magnetic sleep-aiding pillow |
| 08/28/2013 | CN103270022A Agonists of neurotrophin receptors and their use as medicaments |
| 08/28/2013 | CN103269719A Immunogenic compositions and methods for treating neurologic disorders |
| 08/28/2013 | CN103269709A Treatment of sanfilippo syndrome type b |
| 08/28/2013 | CN103269708A Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| 08/28/2013 | CN103269700A Picropodophyllin polymorphs b or c for use in cancer therapy |
| 08/28/2013 | CN103269699A Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin |
| 08/28/2013 | CN103265606A Hederagenin amide derivative and preparation method and application thereof |
| 08/28/2013 | CN103265593A Icariin derivatives |
| 08/28/2013 | CN103265591A Icariin derivative, and preparation method and application thereof |
| 08/28/2013 | CN103265517A 3-substituted coumarin derivative and use thereof |
| 08/28/2013 | CN103265480A Quinolinedione derivative, and preparation method and use thereof |
| 08/28/2013 | CN103265432A Drug for treating cancer pain |
| 08/28/2013 | CN103265431A Compound for treating cancer pain |
| 08/28/2013 | CN103263670A Diazepam nasal delivery preparation and preparation method thereof |
| 08/28/2013 | CN103263664A Method for preventing and treating alzheimer's disease |
| 08/28/2013 | CN103263658A Traditional Chinese medicine preparation for treating peripheral facial paralysis and preparation method thereof |
| 08/28/2013 | CN103263644A Traditional Chinese medicine for treating neurodermatitis |
| 08/28/2013 | CN103263606A Traditional Chinese medicine composition for treating diabetic foot by foot bath nursing and application of traditional Chinese medicine composition |
| 08/28/2013 | CN103263598A Chinese medicine preparation for treating peripheral facial paralysis diseases |
| 08/28/2013 | CN103263596A Compound essential oil for treating insomnia |
| 08/28/2013 | CN103263590A Traditional Chinese medicine external application preparation for treating facial neuritis |
| 08/28/2013 | CN103263575A Medicine for treating headache and preparation method thereof |
| 08/28/2013 | CN103263549A Chinese medicine fumigating and washing agent for treating diabetic feet |
| 08/28/2013 | CN103263535A Traditional Chinese medicine composition for treating lateral femoral cutaneous neuritis |
| 08/28/2013 | CN103263531A Chinese medicine composition for treating prosopalgia and preparation method thereof |
| 08/28/2013 | CN103263526A Tumor, bone spurs, hyperplasia and blood stasis dispersing paste |
| 08/28/2013 | CN103263513A Application of traditional Chinese medicine in preparation of drugs for paranoid psychosis |
| 08/28/2013 | CN103263506A Application of medicine in preparation of drugs for paranoid psychosis |
| 08/28/2013 | CN103263505A Medicine for treating schizophrenia |
| 08/28/2013 | CN103263494A Traditional Chinese medicine health product with functions of calming nerves and helping sleep |
| 08/28/2013 | CN103263467A Potent medicament of brain-and-heart, preparation method and content determination |
| 08/28/2013 | CN103263455A Preparation and application of medicine with neuroprotective effect |